HOW COST-EFFECTIVE ARE PHARMACO- AND BEHAVIORAL THERAPIES FOR SMOKING CESSATION?
Many interventions exist to aid smokers in cessation attempts. Smoking cessation therapies can be classified as pharmacotherapies or behavioral therapies. Both pharmaco- and behavioral therapies for smoking cessation are cost-effective and even cost-saving in achieving public health and medical goals. The review highlights several shortcomings in methodology and a lack of standardization of current economic evaluations. Efforts to improve methodology will help make future studies more comparable and increase the evidence base so that such evaluations can be more useful to public health practitioners and policy makers.
BACK TO SMOKING CESSATION AND RELAPSE PREVENTION
BACK TO SUBSTANCE ABUSE AND MENTAL DISORDERS
BACK TO ECONOMIC EVALUATION OF ADDICTION TREATMENT AND RISKY BEHAVIOR PREVENTION